On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
In this talk, I will explore the impact of low-frequency mutations on the evolution of drug-resistant HIV, highlighting our breakthroughs with the AMPHEUS system and veSEQ pipeline for advanced genomic analyses. Our findings reveal crucial insights into the underestimated prevalence of transmitted NRTI resistance, underscoring the urgent need for enhanced surveillance in areas with high treatment failure rates.
David Bonsall, is a pioneer of pathogen genomics, leads efforts to unravel the complexities of drug resistant in HIV, leveraging cutting-edge technologies to inform global health strategies.
